Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
INSM
INSM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest INSM ETF News Today | Earnings, Events & Price Alerts
INSM News
Baker Bros. Advisors Increases Stake in Kymera Therapeutics
Feb 23 2026
Yahoo Finance
Insmed's Q4 Update Boosts Confidence in Brinsupri Launch Trajectory
Feb 20 2026
Yahoo Finance
US Stocks Close Lower Amid AI Outlook Concerns
Feb 20 2026
NASDAQ.COM
Insmed Q4 2025 Earnings Call Highlights
Feb 19 2026
seekingalpha
Insmed Reports 2025 Financial Results and 2026 Revenue Guidance
Feb 19 2026
PRnewswire
Insmed Reports 2025 Financials and 2026 Revenue Guidance
Feb 19 2026
Newsfilter
Insmed Reports Q4 Earnings with Revenue Growth and Future Projections
Feb 19 2026
seekingalpha
Insmed Set to Announce Q4 Earnings on February 19
Feb 18 2026
seekingalpha
Insmed to Present at Upcoming Investor Conferences
Feb 13 2026
PRnewswire
Insmed to Present at Upcoming Investor Conferences
Feb 13 2026
Newsfilter
Stan Druckenmiller: The Influential Figure Behind Bessent and Warsh, Potential Candidates for Fed Chair
Feb 02 2026
Barron's
Definium Appoints Roger Adsett to Board of Directors to Drive Growth
Jan 29 2026
Yahoo Finance
Insmed to Present TPIP Study Findings at PVRI 2026 Congress
Jan 28 2026
PRnewswire
Insmed to Present TPIP Research Findings at PVRI 2026 Congress
Jan 28 2026
Newsfilter
Roth Initiates Insmed (INSM) at Buy with $212 Price Target, Sees Strong Sales Potential
Jan 23 2026
seekingalpha
Insmed Initiated at Buy by Roth with $212 Price Target, 32% Upside Potential
Jan 23 2026
CNBC
Show More News
